The Effects of Increasing Plasma Concentrations of Dexmedetomidine in Humans

By T. Ebert, J. Hall, J. A. Barney, T. Uhrich, Maelynn D. Colinco. Anesthesiology, 2000

1,466 citations recorded by the source corpus.

Subfields: Anesthesiology and Pain Medicine, Critical Care and Intensive Care Medicine, Small Animals

View Paper: https://www.semanticscholar.org/paper/935ca92aebbdb2f70e42a3169eb55838c8ea74d8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. P. Colin
2. M. Struys
3. Maud A. S. Weerink
4. H. Brown
5. Erin N. Silvius
6. A. Absalom
7. R. Gertler
8. Laura N Hannivoort

Citations in the corpus

• Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine (2017, background): “A sustained dose-dependent reduction in circulating plasma catecholamines by 60–80%, as found in multiple studies, is consistent with these long-lasting sympatholytic effects of dexmedetomidine [9, 38, 57].”
• Dexmedetomidine: A Novel Sedative-Analgesic Agent (2001, background): “Possible anesthetic effects also have been suggested in humans (28).”